Patient-derived cellular systems enable individualized therapeutic testing and precision medicine strategies tailored to specific genetic backgrounds.
Precision & Personalized Medicine
Key Applications
Develop patient-specific models to predict therapeutic response and support precision medicine strategies. Every patient is unique, and responses to treatment can vary significantly between individuals.
By reprogramming patient samples into induced pluripotent stem cells (iPSCs) and differentiating them into disease-relevant cells and organoids, Nocteva builds personalized models that faithfully capture each patient's genetic and biological profile. Combined with advanced phenotypic profiling, this gives a powerful platform for evaluating therapeutic efficacy, pinpointing responsive patient populations, and advancing precision medicine.
Patient-Specific Disease Modeling
Reprogram patient-derived iPSCs into disease-relevant cells and organoids that preserve each patient's unique genetic background — capturing the biology that drives individual disease.
Treatment Response Prediction
Evaluate how individual patient-derived models respond to candidate therapies, gene therapies, or small molecules.
Patient Stratification
Identify patient subgroups with distinct molecular or functional characteristics to support precision therapeutic strategies.
Biomarker-Guided Medicine
Combine patient-derived models with biomarker discovery to identify predictors of treatment response and disease progression.
Contact
Interested in our services?
We collaborate with researchers, clinicians, and patient communities to drive innovation where it’s needed most.
Your submission has been received!
Oops! Something went wrong while submitting the form.